Investing.com -- Former Fed Governor, Kevin Warsh, who is also seen as a frontrunner if President Donald Trump decides to ...

Investing.com -- The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced a new joint research initiative today, aimed at addressing the rising tide of ...

The stable outlook reflects S&P Global Ratings’ expectation that Hudbay will generate steady average credit measures, including adjusted debt to EBITDA of 2.5x-3.5x over the next couple of years, and ...

Investing.com -- High-ranking officials from Europe are currently in discussions with the Trump administration to reach a consensus on a 30-day ceasefire in Ukraine. As per Bloomberg, citing sources ...

The stable outlook reflects S&P Global Ratings’ expectation that Amgen’s revenue and EBITDA will remain stable despite patent expirations and the impact of the Inflation Reduction Act. It also ...

“Weakness persists as the trade war weighs,” Macquarie said, pointing to declines in manufacturing (-31K) and wholesale and ...